Hereditary cystatin C amyloid angiopathy is a dominantly inherited disease caused by a leucine to glutamine variant of human cystatin C (hCC). L68Q-hCC forms amyloid deposits in brain arteries associated with micro-infarcts, leading ultimately to paralysis, dementia and death in young adults. To evaluate the ability of molecules to interfere with aggregation of hCC while informing about cellular toxicity, we generated cells that produce and secrete WT and L68Q-hCC and have detected high-molecular weight complexes formed from the mutant protein. Incubations of either lysate or supernatant containing L68Q-hCC with reducing agents glutathione or N-acetyl-cysteine (NAC) breaks oligomers into monomers. Six L68Q-hCC carriers taking NAC had skin biopsies obtained to determine if hCC deposits were reduced following NAC treatment. Remarkably, ~50-90% reduction of L68Q-hCC staining was observed in five of the treated carriers suggesting that L68Q-hCC is a clinical target for reducing agents.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988011 | PMC |
| http://dx.doi.org/10.1038/s41467-021-22120-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer's diseases.
IBRO Neurosci Rep
December 2024
L&J Bio USA, Inc., Gaithersburg, MD 20878, USA.
Article Synopsis
- Neurofibrillary tangles (NFTs), linked to Alzheimer's disease (AD) neurodegeneration, consist of hyperphosphorylated tau proteins, particularly affecting memory in the hippocampus.* -
- The study investigated the effects of AL04, a new protein treatment, on lowering hyperphosphorylated tau in a specific mouse model with human tau mutation, revealing significant decreases in tau levels and changes in autophagy-related proteins.* -
- Findings suggest that AL04 could serve as a potential preventive and therapeutic agent for AD by promoting tau degradation and regulating relevant protein pathways.*
Systemic Lipid Metabolism Dysregulation as a Possible Driving Force of Fracture Non-Unions?
Bioengineering (Basel)
November 2024
Clinic of Traumatology, University Hospital Center "Sestre Milosrdnice", 10000 Zagreb, Croatia.
Introduction: Non-unions are fractures that do not heal properly, resulting in a false joint formation at the fracture site. This condition leads to major health issues and imposes a burden on national healthcare systems. The etiology of non-unions is still not fully understood; therefore, we aimed to identify potential systemic factors that may contribute to their formation.
View Article and Find Full Text PDFBiomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses.
NPJ Parkinsons Dis
November 2024
Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Cognitive impairment (CI) is common in α-synucleinopathies, i.e., Parkinson's disease, Lewy bodies dementia, and multiple system atrophy.
View Article and Find Full Text PDFDevelopment and application of a serious adverse events risk model for concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
Medicine (Baltimore)
August 2024
Department of Nursing, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, China.
The objective of this study was to construct a concise prediction model for serious adverse events (SAEs) in order to assess the likelihood of SAE occurrence among hospitalized patients undergoing concurrent chemoradiotherapy. An electronic database of a Cancer Centre was utilized to conduct a cross-sectional review survey. Our research involved the recruitment of 239 patients who were undergoing concurrent chemoradiotherapy in the Department of Nasopharynx and Radiotherapy.
View Article and Find Full Text PDFDaiTongXiao improves gout nephropathy by inhibiting inflammatory response through the TLR4/MyD88/NF-κB pathway.
Front Pharmacol
August 2024
College of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Article Synopsis
- Gouty nephropathy (GN) is a kidney condition caused by high uric acid levels due to factors like excessive purine intake and metabolic disorders, leading to crystal buildup in kidney tissue.
- DaiTongXiao (DTX), a traditional remedy from the Dai people in China, shows promise in reducing uric acid levels and has anti-inflammatory and kidney-protective effects.
- In a rat model of GN, DTX treatment improved kidney function and structure, decreased serum inflammatory markers, and inhibited the TLR4/MyD88/NF-κB signaling pathway, indicating its potential as a therapeutic option for GN.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!